How should PPIs or H2 blockers be managed in peritoneal dialysis patients with a history of peritonitis and peptic ulcer disease, considering the potential infection risk?

This question should probably be rephrased, with the words "a history of peritonitis and" removed. I am not aware of any literature indicating that the risk of peritonitis with the use of gastric acid suppressants (GAS), either H2 blockers (H2Bs) or proton pump inhibitors (PPIs), is modified by a pr...